Channelpedia

Cav3.3

102 literature references associated to Cav3.3

used / unused
Pubmed id

1

361896

Yang W et al. Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience, 2016 Jan 28 , 313 (213-24).

4

362905

Harraz OF et al. CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol., 2015 May , 145 (405-18).

5

357606

Monteil A et al. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem., 2015 Jun 26 , 290 (16168-76).

6

357640

Elíes J et al. H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun., 2015 Jun 12 , 461 (659-64).

7

357914

Tompkins JD et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).

9

348732

13

348750

14

356522

Elíes J et al. Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol., 2015 , 860 (353-60).

15

363265

Calderón-Rivera A et al. Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
PLoS ONE, 2015 , 10 (e0119134).

18

361006

20

347358

González-Ramírez R et al. Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol., 2014 May , 229 (551-60).

23

341963

Michaela P et al. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Feb , 387 (153-63).

24

350365

Elíes J et al. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J., 2014 Dec , 28 (5376-87).

25

350799

Lee SE et al. Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.
Proc. Natl. Acad. Sci. U.S.A., 2014 Aug 12 , 111 (11828-33).

27

352855

Chemin J et al. Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch., 2014 Apr , 466 (689-700).

28

353225

Shuba YM Models of calcium permeation through T-type channels.
Pflugers Arch., 2014 Apr , 466 (635-44).

30

351509

Bladen C et al. Block of T-type calcium channels by protoxins I and II.
Mol Brain, 2014 , 7 (36).

31

344489

Elies J et al. OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide, 2013 Sep 1 , 31 Suppl 2 (S27-8).

32

342255

Seo H et al. Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther., 2013 Nov , 347 (310-7).

34

341189

36

338155

Zhang Y et al. Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta, 2013 Jul , 1828 (1550-9).

38

342979

39

343436

Shan HQ et al. Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res., 2013 Aug , 37 (1333-42).

40

336303

Waszkielewicz AM et al. Ion channels as drug targets in central nervous system disorders.
Curr. Med. Chem., 2013 , 20 (1241-85).

41

347218

Sekiguchi F et al. T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci., 2013 , 122 (244-50).

44

332042

Lopez-Charcas O et al. Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol., 2012 Oct , 82 (658-67).

45

337516

Kirkton RD et al. Genetic engineering of somatic cells to study and improve cardiac function.
Europace, 2012 Nov , 14 Suppl 5 (v40-v49).

47

326831

Balderas E et al. Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol., 2012 Jun , 227 (2542-55).

48

331474

55

325720

Lacinová L T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys., 2011 Dec , 30 (403-9).

56

330130

Brunner JI et al. Pharmacological validation of candidate causal sleep genes identified in an N2 cross.
J. Neurogenet., 2011 Dec , 25 (167-81).

57

323212

Astori S et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A., 2011 Aug 16 , 108 (13823-8).

63

318529

Cain SM et al. Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin), 2010 Nov-Dec , 4 (475-82).

64

319935

Anderson D et al. Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin), 2010 May-Jun , 4 (163-7).

65

318733

Bae J et al. Interaction of T-type calcium channel Ca(V)3.3 with the β-subunit.
Mol. Cells, 2010 Sep , 30 (185-91).

67

141643

68

137096

Strege PR et al. T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol., 2010 May , 298 (G706-13).

69

139246

71

121647

74

123982

79

17909

80

15277

Traboulsie A et al. Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.), 2007 Jan 1 , 578 (159-71).

81

19510

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

82

29381

Nordskog BK et al. Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience, 2006 Sep 1 , 141 (1365-73).

83

13429

86

11535

89

14231

Perez-Reyes E et al. Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (605-9).

90

20771

Perez-Reyes E Molecular characterization of T-type calcium channels.
Cell Calcium, 2006 Aug , 40 (89-96).

91

28954

Lory P et al. T-type calcium channels in differentiation and proliferation.
Cell Calcium, 2006 Aug , 40 (135-46).

94

39536

Park JY et al. Multiple structural elements contribute to the slow kinetics of the Cav3.3 T-type channel.
J. Biol. Chem., 2004 May 21 , 279 (21707-13).

95

37017

Mudado MA et al. CaV 3.1 and CaV 3.3 account for T-type Ca2+ current in GH3 cells.
Braz. J. Med. Biol. Res., 2004 Jun , 37 (929-35).

96

30882

Murbartián J et al. Functional impact of alternative splicing of human T-type Cav3.3 calcium channels.
J. Neurophysiol., 2004 Dec , 92 (3399-407).

97

32396

Yunker AM Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.
J. Bioenerg. Biomembr., 2003 Dec , 35 (577-98).